| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.006 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.006 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.007 |